GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

A GSK medicine that was pulled from the market after failing its confirmatory test in multiple myeloma has new data from a Phase 3 study evaluating it as an earlier line of treatment, and the ...

LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a comeback. In the study, a treatment ...

For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

It is believed that the drug may become the company’s biggest single medicine by 2031. Following the data release, GSK’s stock price jumped nearly 3% in after-hours trading. In a world where ...

GSK plc and Medicines for Malaria Venture (MMV) announced that the World Health Organization (WHO) has awarded prequalification to tafenoquine, the first single-dose medicine for the prevention of ...

GSK hosted the third annual RespiVerse meeting on December 13-14 in Bangkok, Thailand, bringing together renowned ...

With GSK shipping 500 million vaccine doses and up to 1.8 billion packs of medicine last year, the scalability benefits are clear. A challenge not isolated to the pharmaceutical sector is getting ...